Get the Stockscreener App
0.5831
1.50%
-0.0089
Pre-market:
.60
0.0169
+2.90%
Century Therapeutics Inc stock is traded at $0.5831, with a volume of 652.47K.
It is down -1.50% in the last 24 hours and up +17.09% over the past month.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
See More
Previous Close:
$0.592
Open:
$0.59
24h Volume:
652.47K
Relative Volume:
0.93
Market Cap:
$50.37M
Revenue:
$2.24M
Net Income/Loss:
$-136.67M
P/E Ratio:
-0.2546
EPS:
-2.29
Net Cash Flow:
$-102.08M
1W Performance:
+1.00%
1M Performance:
+17.09%
6M Performance:
+7.66%
1Y Performance:
-49.30%
1-Day Range:
$0.5756
$0.60
1-Week Range:
$0.552
$0.63
52-Week Range:
$0.3418
$1.83
Century Therapeutics Inc Stock (IPSC) Company Profile
Name
Century Therapeutics Inc
Sector
Industry
Phone
215-981-4000
Address
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Compare IPSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5831 | 51.14M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-28-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-27-22 | Initiated | Chardan Capital Markets | Buy |
| Oct-31-22 | Initiated | Guggenheim | Buy |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| May-23-22 | Initiated | H.C. Wainwright | Buy |
| May-12-22 | Initiated | William Blair | Mkt Perform |
| Jul-13-21 | Initiated | BofA Securities | Buy |
| Jul-13-21 | Initiated | JP Morgan | Overweight |
| Jul-13-21 | Initiated | Piper Sandler | Overweight |
View All
Century Therapeutics Inc Stock (IPSC) Latest News
Century Therapeutics Inc. stock trend outlook and recovery pathTake Profit & Verified Entry Point Signals - newser.com
What Fibonacci levels say about Century Therapeutics Inc. rebound2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
What does recent volatility data suggest for Century Therapeutics Inc.Quarterly Trade Summary & Fast Entry Momentum Trade Alerts - newser.com
Published on: 2025-11-03 01:13:25 - newser.com
How to manage a losing position in Century Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com
How Century Therapeutics Inc. stock compares to industry benchmarksPortfolio Return Summary & Short-Term Trading Alerts - newser.com
Century Therapeutics Inc. stock trendline breakdownTrade Ideas & Real-Time Chart Breakout Alerts - newser.com
Is Century Therapeutics Inc a good long term investmentStop Loss Placement Tips & Small Entry Portfolio - earlytimes.in
Visual analytics tools that track Century Therapeutics Inc. performanceInsider Buying & Short-Term Trading Alerts - newser.com
Can volume confirm reversal in Century Therapeutics Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Published on: 2025-11-01 08:35:05 - newser.com
Does Century Therapeutics Inc. show high probability of reboundMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
Custom strategy builders for tracking Century Therapeutics Inc.2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com
Century Therapeutics Inc. stock volume spike explained2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Decreases By 74.9% - MarketBeat
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Century Therapeutics Inc. stock overvalued by current metrics2025 Fundamental Recap & Risk Controlled Daily Plans - fcp.pa.gov.br
Century Therapeutics Inc. stock momentum explainedMarket Performance Report & AI Powered Market Entry Strategies - newser.com
Is Century Therapeutics Inc. stock a top pick in earnings season2025 Macro Impact & Short-Term High Return Ideas - Fundação Cultural do Pará
Century Therapeutics’ CALiPSO-1 Study: A Promising Step in Autoimmune Disease Treatment - TipRanks
Century Therapeutics’ Long-Term Follow-Up Study: Key Insights for Investors - TipRanks
How sustainable is Century Therapeutics Inc. stock dividend payoutInsider Buying & AI Forecast for Swing Trade Picks - fcp.pa.gov.br
Century Therapeutics Inc Stock (IPSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):